BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 33920536)

  • 1. Precision Oncology Beyond Genomics: The Future Is Here-It Is Just Not Evenly Distributed.
    Pfohl U; Pflaume A; Regenbrecht M; Finkler S; Graf Adelmann Q; Reinhard C; Regenbrecht CRA; Wedeken L
    Cells; 2021 Apr; 10(4):. PubMed ID: 33920536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future.
    Akhoundova D; Rubin MA
    Cancer Cell; 2022 Sep; 40(9):920-938. PubMed ID: 36055231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision oncology in the age of integrative genomics.
    Kumar-Sinha C; Chinnaiyan AM
    Nat Biotechnol; 2018 Jan; 36(1):46-60. PubMed ID: 29319699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and genomic learning needs of oncologists and oncology nurses in the era of precision medicine: a scoping review.
    Rahman B; McEwen A; Phillips JL; Tucker K; Goldstein D; Jacobs C
    Per Med; 2022 Mar; 19(2):139-153. PubMed ID: 35060769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular diagnostics tailoring personalized cancer therapy-an oncologist's view.
    Riedl JM; Moik F; Esterl T; Kostmann SM; Gerger A; Jost PJ
    Virchows Arch; 2024 Feb; 484(2):169-179. PubMed ID: 37982847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Precision Oncology and "Molecular Tumor Boards" - Concepts, Chances and Challenges].
    Holch JW; Westphalen CB; Hiddemann W; Heinemann V; Jung A; Metzeler KH
    Dtsch Med Wochenschr; 2017 Nov; 142(22):1676-1684. PubMed ID: 29078213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine.
    McGowan ML; Settersten RA; Juengst ET; Fishman JR
    Urol Oncol; 2014 Feb; 32(2):187-92. PubMed ID: 24445286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing precision cancer medicine in the genomic era.
    Chen HZ; Bonneville R; Roychowdhury S
    Semin Cancer Biol; 2019 Apr; 55():16-27. PubMed ID: 29857039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenging Standard-of-Care Paradigms in the Precision Oncology Era.
    Subbiah V; Kurzrock R
    Trends Cancer; 2018 Feb; 4(2):101-109. PubMed ID: 29458960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine.
    Jose A; Kulkarni P; Thilakan J; Munisamy M; Malhotra AG; Singh J; Kumar A; Rangnekar VM; Arya N; Rao M
    Mol Cancer; 2024 Mar; 23(1):50. PubMed ID: 38461268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.
    Perera-Bel J; Hutter B; Heining C; Bleckmann A; Fröhlich M; Fröhling S; Glimm H; Brors B; Beißbarth T
    Genome Med; 2018 Mar; 10(1):18. PubMed ID: 29544535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel omics technology driving translational research in precision oncology.
    Basu A; Budhraja A; Juwayria ; Abhilash D; Gupta I
    Adv Genet; 2021; 108():81-145. PubMed ID: 34844717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of Genomic Profiling and Organoid Development in Precision Oncology.
    Yoon H; Lee S
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-omics strategies for personalized and predictive medicine: past, current, and future translational opportunities.
    Ahmed Z
    Emerg Top Life Sci; 2022 Apr; 6(2):215-225. PubMed ID: 35234253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organoids: An intermediate modeling platform in precision oncology.
    Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
    Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomics and bioinformatics as pillars of precision medicine in oncology.
    Canzoneri R; Lacunza E; Abba MC
    Medicina (B Aires); 2019; 79(Spec 6/1):587-592. PubMed ID: 31864231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer.
    Li J; Li L; You P; Wei Y; Xu B
    Semin Cancer Biol; 2023 Jun; 91():35-49. PubMed ID: 36868394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matching cancer genomes to established cell lines for personalized oncology.
    Dudley JT; Chen R; Butte AJ
    Pac Symp Biocomput; 2011; ():243-52. PubMed ID: 21121052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparity between Inter-Patient Molecular Heterogeneity and Repertoires of Target Drugs Used for Different Types of Cancer in Clinical Oncology.
    Zolotovskaia MA; Sorokin MI; Petrov IV; Poddubskaya EV; Moiseev AA; Sekacheva MI; Borisov NM; Tkachev VS; Garazha AV; Kaprin AD; Shegay PV; Giese A; Kim E; Roumiantsev SA; Buzdin AA
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision Medicine in Veterinary Science.
    Chon E; Hendricks W; White M; Rodrigues L; Haworth D; Post G
    Vet Clin North Am Small Anim Pract; 2024 May; 54(3):501-521. PubMed ID: 38212188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.